Becker's Healthcare September 16, 2024
Claire Wallace

New data from cancer screening and diagnostic test provider Exact Sciences have shown an 88.3% sensitivity rate for its blood-based colorectal cancer screening test.

The blood test also showed 31.2% sensitivity for advanced precancerous lesions at specificity of 90.1% for negative samples confirmed by colonoscopy, according to a Sept. 16 press release.

The study consisted of more than 3,000 blood samples, including approximately 2,900 blinded, using an analysis that was prespecified by the FDA.

The study also included more than 90 advanced...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Medical Devices, Provider
UN warns of military brain control
Only 20% of AI devices for children used pediatric data to train: 3 notes
Medtech firms have cut thousands of jobs this year. Will layoffs continue in 2025?
Proton therapy market in the US projected to reach $2.67 billion by 2033
How Trump’s second term will affect the medtech industry

Share This Article